[1] Bedosa P,Paradis V. Transforming growth factor-β(TGF-β):a key-role in liver fibrogenesis. J Hepatol,1995,22:37-42. [2] Lewindon PJ,Pereira TN,Hoskins AC,et al. The role of hepatic stellate cells and transforming growth factor-β1 in cystic fibrosis liver disease. Am J Pathol,2002,160:312-315. [3] Date M,Matsuzaki K,Matsushita M,et al. Modulation of transforming growth factor function in hepatocytes and hepatic stellate cells in rat liver injury. Gut,2000,46:719-724. [4] Wada W,Kuwano H,Hasegawa Y,et al. The Dependence of transforming growth factor-β-induced collagen production on autocrine factor activin A in hepatic stellate cells. Endocrinology,2004,145:2753-2759. [5] Shao R,Shi ZD,Gotwals PJ,et al. Cell and molecular regulation of endothelin-1 production during hepatic wound healing. Mol Cell Biol,2003,14:2327-2341. [6] Kojima S,Hayashi S,Shimokado K,et al. Transcriptional activation of urokinase by the Kruppel-like factor Zf9/COPEB activated latent TGF-beta1 in vascular endothelial cells. Blood,2000,15:1309-1310. [7] del Re E,Babitt JL,Pirani A,et al. In the absence of type III receptor,the transforming growth factor (TGF)-β type II-B receptor requires the type I receptor to bind TGF-β2. J Biol Chem,2004,279:22765-22772. [8] Nie QH,Duan GR,Luo XD,et al. Expression of TIMP-1 and TIMP-2 in rats with hepatic fibrosis. World J Gastroenterol,2004,10:86-95. [9] Boeker KH,Haberkorn CI,Michel D,et al. Diagnostic potential of circulating TIMP-1 and MMP-2 as markers of liver fibrosis in patients with chronic hepatitis C. Clin Chim Acta,2002,316:71-79. [10] Lichtinghagen R,Matthias J,Michael P,et al. Expression and regulation of matrix metalloproteinases in chronic hepatitis C and hepatitis C virus-induced liver cirrhosis.Clin Sci,2003,105:373. [11] Nie QH,Cheng YQ,Xie YM,et al. The inhibiting effect of antisense oligonucleotides phosphorothioate on gene expression of TIMPs in rat liver fibrosis. Gastroenterology,2001,7:363. [12] 杨长青,胡国龄,谭德明,等.基质金属蛋白酶-1、反义金属蛋白酶组织抑制因子-1表达质粒对大鼠肝纤维化的影响. 中华传染病杂志,2000,18(1):29-32. [13] Knittel T,Mehde M,Koblod D,et al.Expression patterns of matrix metelloproteinases and their inhibitors in parenchymal and nonparenchymal cells of rat livers:regulation by TNF alfa and TGF beta. J Hepatol,1999,30(1):48-60. [14] 李紫琼,郑勇. TIMPS和MMPS与肝纤维化研究进展. 实用肝脏病杂志,2007,10(5):355-358. [15] 李紫琼,郑勇,李睿,等. 反义TIMP-1表达质粒对实验性肝纤维化的影响. 胃肠病学和肝病学杂志,2008,17(4):325-328. [16] 李紫琼,木尼拉,高峰.反义TIMP-1质粒对实验性肝纤维化中TIMP-1、MMP-13蛋白的影响. 实用医学,2013,10:1561-1563. [17] 黄宁,曾令兰,李淑莉,等. TGF-β1、BMP-7 mRNA在实验性肝纤维化中的表达及意义. 微循环学杂志,2007,3:20-21. [18] 高萍,邵泽勇,刘春,等.木疏胶囊抗大鼠肝纤维化机制研究. 山西医科大学学报,2010,41(7):579. [19] 刘燕,左和宁,杨伟峰. 联用阿米洛利与川芎嗪预防大鼠肝纤维化的实验研究. 临床医学工程,2010,17(7):49. [20] 赖景绍,蔡红兵,陈文倩,等. 大黄蜃虫丸抗实验性肝纤维化的功效组分研究. 时珍国医国药,2010,21(6):1322. |